RecruitingNot ApplicableNCT06321471

AeviceMD for Pediatric Asthma Management


Sponsor

Irina Dralyuk

Enrollment

20 participants

Start Date

Nov 5, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

A wearable remote patient monitor (AeviceMD) is to be used to monitor the respiratory health of pediatric asthma patients in this pilot study. Patients prescribed with AeviceMD should be able to gain better control over their disease during home management. Physicians should be able to optimize treatment for these patients using objective data collected from and of these patients outside of the clinic. The AeviceMD should also be used as a remote auscultation device for teleconsultations.


Eligibility

Min Age: 3 YearsMax Age: 18 Years

Inclusion Criteria9

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Aged 3 to 18 as of first recruitment
  • Diagnosed with poorly controlled asthma
  • Asthma control test score below
  • Caregiver able operate a mobile application
  • Has access high-speed wireless internet (WiFi) at home
  • Able to read English
  • Agreement to adhere to medical device use regimen throughout the study duration

Exclusion Criteria3

  • Known allergy to silicone, gold, or zinc
  • Abnormal skin conditions on chest
  • Sleep apnea diagnosis

Interventions

DEVICEAeviceMD

AeviceMD is a remote patient monitoring system consisting of a wearable stethoscope, silicone patches, a docking station, and a mobile application.


Locations(1)

Cedars-Sinai Medical Center

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06321471


Related Trials